Predator-elicited flight responses in Swiss-Webster an experimental model of panic attacks

被引:60
作者
Griebel, G [1 ]
Blanchard, DC [1 ]
Blanchard, RJ [1 ]
机构
[1] UNIV HAWAII, BEKESY LAB NEUROBIOL, HONOLULU, HI 96822 USA
关键词
animal model; antipredator defense; benzodiazepine receptor ligands; flight; panic; serotonin receptor ligands; serotonin reuptake inhibitors; swiss-webster mouse;
D O I
10.1016/0278-5846(95)00305-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1. The nosological status of panic disorder is still a matter of debate. Nevertheless, evidence is emerging that panic attacks have a different pattern of drug responsiveness from other forms of anxiety. 2. Several experimental animal models of panic attacks have been developed. These vary in the extend to which they meet criteria for face validity, predictive validity and construct validity, normally applied to such models. 3. In the present review, the authors examine the possibility that predator-elicited flight responses in Swiss-Webster mice might serve as an experimental model for the screening of panic-modulating drugs. 4. Drug effects on flight responses clearly indicate that this model has good predictive validity as panic-promoting agents increase flight reactions, while panicolytic drug challenge induces opposite effects. In addition, drugs devoid of any effect on panic attack, also do not alter flight behavior. 5. These findings strongly suggest that the model of predator-elicited flight responses in Swiss-Webster mice is useful for the investigation of panic-modulating drugs.
引用
收藏
页码:185 / 205
页数:21
相关论文
共 81 条
[1]  
ASHCROFT GW, 1993, PSYCHOPHARMACOLOGY P, P131
[2]  
BEAUDRY P, 1986, J CLIN PSYCHIAT, V47, P83
[3]   THE BENZODIAZEPINE RECEPTOR INVERSE AGONISTS BETA-CCM AND RO 15-3505 BOTH REVERSE THE ANXIOLYTIC EFFECTS OF ETHANOL IN MICE [J].
BELZUNG, C ;
MISSLIN, R ;
VOGEL, E .
LIFE SCIENCES, 1988, 42 (18) :1765-1772
[4]   ANXIOGENIC EFFECTS OF A BENZODIAZEPINE RECEPTOR PARTIAL INVERSE AGONIST, RO-19-4603, IN A LIGHT DARK CHOICE SITUATION [J].
BELZUNG, C ;
MISSLIN, R ;
VOGEL, E .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 36 (03) :593-596
[5]   DEFENSE SYSTEM PSYCHOPHARMACOLOGY - AN ETHOLOGICAL APPROACH TO THE PHARMACOLOGY OF FEAR AND ANXIETY [J].
BLANCHARD, RJ ;
YUDKO, EB ;
RODGERS, RJ ;
BLANCHARD, DC .
BEHAVIOURAL BRAIN RESEARCH, 1993, 58 (1-2) :155-165
[6]   YOHIMBINE POTENTIATES ACTIVE DEFENSIVE RESPONSES TO THREATENING STIMULI IN SWISS-WEBSTER MICE [J].
BLANCHARD, RJ ;
TAUKULIS, HK ;
RODGERS, RJ ;
MAGEE, LK ;
BLANCHARD, DC .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 44 (03) :673-681
[7]   FLUOXETINE IN PANIC DISORDER PATIENTS WITH IMIPRAMINE-ASSOCIATED WEIGHT-GAIN [J].
BRADY, K ;
ZARZAR, M ;
LYDIARD, RB .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1989, 9 (01) :66-67
[8]   ADVERSE-EFFECTS ASSOCIATED WITH THE SHORT-TERM TREATMENT OF PANIC DISORDER WITH IMIPRAMINE, ALPRAZOLAM OR PLACEBO [J].
CASSANO, GB ;
TONI, C ;
PETRACCA, A ;
DELTITO, J ;
BENKERT, O ;
CURTIS, G ;
HIPPIUS, H ;
MAIER, W ;
SHERA, D ;
KLERMAN, G .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1994, 4 (01) :47-53
[9]  
CHARNEY DS, 1986, J CLIN PSYCHIAT, V47, P580
[10]   SEROTONIN FUNCTION IN ANXIETY .2. EFFECTS OF THE SEROTONIN AGONIST MCPP IN PANIC DISORDER PATIENTS AND HEALTHY-SUBJECTS [J].
CHARNEY, DS ;
WOODS, SW ;
GOODMAN, WK ;
HENINGER, GR .
PSYCHOPHARMACOLOGY, 1987, 92 (01) :14-24